The NGS-Based RNA-Sequencing Market in 2023 is US$ 2.94 billion, and is expected to reach US$ 10.61 billion by 2031 at a CAGR of 17.40%.
FutureWise Research published a report that analyzes NGS-Based RNA-Sequencing Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.
Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This NGS-Based RNA-Sequencing research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.
Request a Sample Report @ Request for NGS-Based RNA-Sequencing Market Sample
NGS-Based RNA-Sequencing Market Segmentation:
By Product & Service
- Sample Preparation Products
- By Workflow
- Library Preparation and Target Enrichment
- Quality Control
- By Method
- Manual Sample Preparation
- Microfluidic Sample Preparation
- Robotic Liquid Handling Sample Preparation
- RNA Sequencing Platforms and Consumables
- RNA Sequencing Services
- Data Analysis, Storage & Management
- By Workflow
By Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Single-molecule Real-time Sequencing
- Nanopore Sequencing
By Application
- Expression Profiling Analysis
- Small RNA Sequencing
- De Novo Transcriptome Assembly
- Variant Calling and Transcriptome Epigenetics
By End User
- Research and Academia
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Other End Users
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Major players included in the NGS-Based RNA-Sequencing Market:
- Agilent Technologies
- BGI Group
- Eurofins Scientific
- Genewiz (Part of Brooks Automation)
- Hamilton Company
- Illumina
- Nugen Technologies (Part of F. Hoffmann-La Roche AG Trading AG)
- Oxford Nanopore Technologies
- Perkinelmer
- Qiagen
- Hoffmann-La Roche AG
- Takara Bio
- Thermo Fisher Scientific
- Zymo Research
- Psomagen
Please visit full report of the NGS-Based RNA-Sequencing market @ Visit NGS-Based RNA-Sequencing Market
Competitive Landscape:
- Tier one players – market players with a significant share of the market
- Tier two players
- Players with rapid growth
- New Entries
FutureWise Key Takeaways:
- Prospects for growth
- Analysis of SWOT
- Key trends
- Key Data-points affecting market growth
Objectives of the Study:
- To provide report with an in-depth analysis of the NGS-Based RNA-Sequencing Market By Product & Service, By Technology, By Application, By End User and By Region
- To offer data-points and comprehensive data on factors affecting the market (Opportunities, drivers, and industry-specific restraints)
- Analysis and forecasting of micro-markets, as well as the scope of the market.
- To predict the size and share, market forecast, in key regions — North America, Europe, Asia Pacific, and rest of the world
- To record and evaluate competition -mergers and expansions, product launches, and technological advancements within the market
Related Markets:
Flexible Delivery Model:
- With our flexible delivery model, you will be able to suggest changes within the scope/table of content based on your requirement.
- Customization services are included with the purchase of any license type of report.
- Customization requests can be sent directly to: sales@futurewiseresearch.com
FutureWise Research:
Contact Person: Vinay T.
Email: sales@futurewiseresearch.com
Contact Number: UK: +44 1416289353 | US: +1 3477094931
Website: www.futurewiseresearch.com
